Related videos
Making Products Better Together with Novozymes Biopharma
At Novozymes, we combine the specific application knowledge of our customers with our unique...
Albumin-based Half-life Extension
The albumin based technology can be used for the reduction of drug dosing frequency and the increase of patient compliance. Genetic fusion – Albufuse® Flex is suitable for non-synthetic peptides whereas chemical conjugation – Recombumin® Flex is most appropriate for non-natural or synthesized peptides.
Date
September 04, 2012
Views (3,280)
Related videos
October 19, 2023 | 05:16
TECO 2023
TECO 2023 was held in Sao Paulo, Brazil. Novozymes was honored to host the leading corn ethanol...
January 11, 2013 | 03:55
Making Products Better Together with Novozymes Biopharma
At Novozymes, we combine the specific application knowledge of our customers with our unique...
September 08, 2022 | 50:47
SEA Waste Differently
Protein toolbox for fish waste processing
May 26, 2020 | 01:16
Novozymes: Medilink East Midlands Business Awards 2012
Novozymes' next generation half-life extension technology which enables pharmaceutical...
January 28, 2020 | 00:58
Make alternative protein the preferred protein
Wind turbines, solar panels, electric cars. Transformative technologies are evolving. So is the...
November 03, 2023 | 03:10
What is a biosolution - Japanese
October 26, 2023 | 03:10
What is a biosolution - Vietnamese
October 26, 2023 | 03:10